Cargando...
Clinical Trials of Immunomodulation in Ischemic Stroke
Inflammatory mechanisms are currently considered as a prime target for stroke therapy. There is evidence from animal studies that immune signals and mediators can have both detrimental and beneficial effects in particular stages of the disease process. Moreover, several of these mechanisms are turne...
Guardado en:
| Publicado en: | Neurotherapeutics |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer US
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5081130/ https://ncbi.nlm.nih.gov/pubmed/27412685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-016-0458-y |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|